Jpmorgan Chase & CO Augmedix, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$0.75 - $4.18 $31,993 - $178,310
-42,658 Reduced 86.65%
6,573 $5,000
Q1 2024

May 10, 2024
SELL
$3.2 - $5.83 $3,808 - $6,937
-1,190 Reduced 2.36%
49,231 $201,000
Q4 2023

Feb 12, 2024
BUY
$4.34 - $5.93 $206,653 - $282,362
47,616 Added 1697.54%
50,421 $294,000
Q3 2023

Nov 14, 2023
BUY
$3.91 - $5.3 $10,967 - $14,866
2,805 New
2,805 $14,000

Others Institutions Holding AUGX

# of Institutions
48
Shares Held
39.7M
Call Options Held
0
Put Options Held
0
View Full List

About Augmedix, Inc.

AUGX Quotes by TradingView
  • Ticker AUGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,421,200
  • Market Cap $87.9M
  • Description
  • Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes...
More about AUGX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email